Concurrent Use of Ticagrelor with Atorvastatin or Rosuvastatin

Basic Details
Date Posted
Thursday, January 23, 2020
Status
Complete
Medical Product
atorvastatin
rosuvastatin
ticagrelor
Description

In this report we evaluated concurrent use of ticagrelor (all strength, 60mg, and 90mg) with atorvastatin or rosuvastatin in the Sentinel Distributed Database (SDD).

The study period included data from January 1, 2012 to June 30, 2018. We distributed this request to 17 Data Partners on January 8, 2019.

Deliverables (1)
Sentinel Modular Program Report: Concurrent Use of Ticagrelor with Atorvastatin or Rosuvastatin
Additional Details
FDA Center
CDER
Time Period
January 1, 2012 - June 30, 2018
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
AHA Scientific Sessions 2019: Myopathy and Rhabdomyolysis with Concomitant Use of Ticagrelor and High-Intensity Statins in the Elderly
Sentinel Drug Assessment: Brilinta (Ticagrelor) & Concomitant Use with Lipitor (Atorvastatin) or Crestor (Rosuvastatin)